Sucampo Pharmaceuticals, Inc. (SCMP) was a big mover last session with its shares rising nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock is now up nearly 35% in the past one-month time frame.
This biopharmaceutical company has one positive estimate revision in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies more solid trading ahead for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Sucampo currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the Med-Drugs industry include Jazz Pharmaceuticals Public Limited Company (JAZZ), WuXi PharmaTech (Cayman) Inc. (WX) and Sagent Pharmaceuticals, Inc. (SGNT). While Jazz Pharmaceuticals and Wuxi carry a Zacks Rank #1 (Strong Buy), Sagent Pharmaceuticals holds a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment